HA14-1
HA14-1 is a Bcl-2/Bcl-XL antagonist. HA14-1 binds the designated pocket on Bcl-2 with the IC50 of ≈9 μM in competing with the Bcl-2 binding of Flu-BakBH3, and inhibits its function.
Product Specifications
CAS Number
65673-63-4
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Bcl-2 Family
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/HA14-1.html
Concentration
10mM
Purity
98.0
Solubility
DMSO : ≥ 50 mg/mL
Smiles
CCOC(C1=C(N)OC2=CC=C(Br)C=C2[C@@]1([H])[C@H](C#N)C(OCC)=O)=O
Molecular Formula
C17H17BrN2O5
Molecular Weight
409.23
Precautions
H302, H315, H319, H335
References & Citations
[1]Wang JL, et al. Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells. Proc Natl Acad Sci U S A. 2000 Jun 20;97 (13) :7124-9.|[2]Kessel D, et al. Initiation of apoptosis and autophagy by the Bcl-2 antagonist HA14-1. Cancer Lett. 2007 May 8;249 (2) :294-9.|[3]Manero F, et al. The small organic compound HA14-1 prevents Bcl-2 interaction with Bax to sensitize malignant glioma cells to induction of cell death. Cancer Res. 2006 Mar 1;66 (5) :2757-64.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Bcl-2; Bcl-xL
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680802-500 1x 500 µL
CD35 / CR1 (CR1/802), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details ![IL8 (CXCL8) Mouse Monoclonal Antibody [Clone ID: I8-61]](https://cdn.genprice.uk/products/937/68dd189b061270361e8fc452/imageurl/am09177af-n.webp)
AM09177AF-N 500 µg
IL8 (CXCL8) Mouse Monoclonal Antibody [Clone ID: I8-61]
Sign In for Pricing
View Details 
